Speakers 2012

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Penny Abernethy at p.abernethy@oxfordglobal.co.uk

  • Dorothee Ambrosius
    Senior Vice President Biopharmaceuticals Global Process Science, Boehringer Ingelheim
  • Andre Choo
    Senior Scientist, Bioprocessing Technology Institute, Singapore
  • Tobias Carl Cornvik
    Director, School of Biological Sciences, Nanyang Technological University, Singapore
  • Dimiter Dimitrov
    Head Protein Interaction Group and Senior Investigator Center for Cancer Research NCI-Frederick, NIH, USA
  • Antony Dimitrov
    Head Antibody Development Group, Profectus Biosciences
  • Mick Foley
    CSO, AdAlta Pty Ltd, Australia
  • Tariq Haq
    Senior Global Product Manager, BioProcess Production, Biosciences Division, Thermo Fisher Scientific
  • Korinna Henseleit
    Senior Scientist, PolyTherics Limited
  • Syd Johnson
    VP, Antibody Engineering, MacroGenics, Inc.
  • Thomas Jostock
    IBP New Technologies Network Leader, Novartis Pharma AG, Switzerland
  • Harleen Kaur
    Researcher, Fujitsu R&D Laboratories, Fujitsu Asia
  • Rakesh Kumar
    Director-Vaccine Production, Serum Institute of India Ltd
  • Sriram Kumaraswamy
    Global Director of Applications, Pall ForteBio
  • Shawn Leung
    CEO, SinoMab BioScience, Hong Kong
  • Jason Li
    Director of Downstream Processing, Genor Biopharma, CHina
  • Antony Munn
    Head of Development Services, Singapore, Lonza
  • Senior Representative
    Tap Biosystems
  • Ramkrishna (Ramu) Sadhukhan
    Senior Group Leader, Abbott Bioresearch Center, USA
  • Manfred Schuster
    COO, APEIRON Biologics AG, Austria
  • Li Shi
    CEO, Shanghai Zerun Biotechnology Co Ltd, Shanghai, China
  • Lei Sun
    President, Manufacture, AutekBio (Beijing), Inc.
  • Fredrik Sundberg
    Global Director, Strategic Market Development, GE Healthcare
  • Stefanie Urlinger
    Director, Discovery Alliances & Technologies, MorphoSys AG
  • Paul Watt
    CEO, Phylogica Ltd, UK
  • Karen Wen
    Founder and President, Mycenax Biotech, Taiwan
  • William G. Whitford
    Sr. Market Manager, Cell Culture, Thermo Scientific Cell Culture & BioProcessing
  • Michael Yu
    Ph.D. Co- Founder, Innovent Biologics, Inc.
  • Yang Yuansheng
    Research Scientist, Bioprocessing Technology Institute, Singapore
  • Joe Zhou
    CEO, Genor BioPharma Co., Ltd, China
biopharma-testimonial8biopharma-testimonial-4biopharma-testimonial-5biopharma-testimonial-10biopharma-testimonial-1biopharma-testimonial-7biopharma-testimonial9biopharma-testimonial-2biopharma-testimonial-6biopharma-testimonial-3